The Atlantic Americans’ appetite for experimental drugs is reaching new heights—just as the FDA’s capacity to ensure the safety of America’s medicine seems to be diminishing, Nicholas Florko argues:
Americans’ appetite for experimental drugs is reaching new heights—just as the FDA’s capacity to ensure the safety of America’s medicine seems to be diminishing, Nicholas Florko argues: